CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve access to pharmaceuticals in developing countries by exploring academic licensing practices, public-private partnerships, and legislative tools for compulsory licensing. It seeks to make patented drugs more affordable and accessible for neglected populations with unmet health needs.
Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right.
Various complex impediments hinder access, which is the subject of ongoing multidisciplinary studies.
Intellectual Property and product development are two issues that can be used as tools to address the problem of access, particularly to make patented drugs more affordable and accessible.
This proposal addresses three ways of accomplishing this.
The first is how acad…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Neuchatel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
SOUTH AFRICAN MEDICAL RESEARCH COUNCIL
South Africa, Tygerberg
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
